As research in rats reveals a key brain pathway, neuroscientists contemplate how to translate findings in animals to understanding of human compulsions involving food or drugs.

Unless Congress closes a loophole in the orphan drug law, new products containing the opioid addiction treatment buprenorphine could be blocked from the market until 2024.

Getting addiction diagnosis or treatment could make the difference between keeping and losing health care coverage for people with substance use disorder in 17 states.

Despite naloxone recommendations for people who take high-dose opioids, or who have a history of opioid problems, study finds those at risk aren’t getting the overdose rescue drug.

As the opioid crisis unfolded, prescriptions for the narcotic alternative saw a two-fold increase despite unclear evidence of benefit for pain.

New findings about low-income adults with behavioral health conditions, mental health and substance use disorders, suggest importance of continuous coverage